Tecan announces OEM agreement with global diagnostics company

Tecan to supply high-throughput instruments to provide blood banks with flexible pooling and archiving solution

10-Jun-2010 - Switzerland

The Tecan Group announced a global OEM agreement with the diagnostics business of Novartis for the supply of a new high-throughput instrument designed to provide blood banks with a flexible, single-platform pooling and archiving solution. Under the agreement, Tecan will supply instruments that will be used in multiple pooling, archive volume, and workflow configurations to meet the differing needs of blood banks testing individual or pooled donations.

Tecan expects to supply the first instruments in 2010 with additional configurations to follow in 2011 and 2012. Financial details of the agreement were not disclosed.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures
View topic world

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures